Overview
Familial spontaneous pneumothorax (FSP) is a rare inherited condition characterized by the recurrent collapse of the lung (pneumothorax) without an obvious external cause, occurring in two or more members of the same family. A pneumothorax happens when air leaks into the space between the lung and the chest wall (pleural space), causing the lung to partially or fully collapse. Patients typically experience sudden onset of sharp chest pain, shortness of breath (dyspnea), and sometimes a dry cough. The condition predominantly affects the respiratory system and tends to occur in tall, thin individuals, often young adults. Familial spontaneous pneumothorax can occur as an isolated familial trait or as part of broader genetic syndromes. Notably, it is a well-recognized feature of Birt-Hogg-Dubé syndrome (caused by mutations in the FLCN gene), Marfan syndrome (FBN1 gene mutations), vascular Ehlers-Danlos syndrome (COL3A1 mutations), and homocystinuria. When occurring as an isolated familial condition, the genetic basis may involve variations in connective tissue or lung parenchymal structure that predispose to the formation and rupture of subpleural blebs or bullae. Some cases have been linked to mutations in the FLCN gene even without other features of Birt-Hogg-Dubé syndrome. Treatment follows the same principles as for sporadic spontaneous pneumothorax. A small, stable pneumothorax may be managed conservatively with observation and supplemental oxygen. Larger or symptomatic pneumothoraces typically require needle aspiration or chest tube insertion to remove the trapped air and allow the lung to re-expand. For recurrent episodes, surgical intervention such as video-assisted thoracoscopic surgery (VATS) with pleurodesis (a procedure to adhere the lung to the chest wall) or bullectomy may be recommended to prevent further recurrences. Genetic counseling is advised for affected families, and screening for underlying syndromic causes should be considered in all patients presenting with familial pneumothorax.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsChinese University of Hong Kong — PHASE2, PHASE3
Corporacion Parc Tauli — NA
University Hospital, Strasbourg, France — NA
Sohag University
Chiang Mai University — NA
Swedish Medical Center — NA
Ain Shams University — PHASE1, PHASE2
Chinese University of Hong Kong
Rennes University Hospital — NA
Steritalc: FDA approved
Steritalc is indicated in adults to decrease the recurrence of pneumothorax.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Familial spontaneous pneumothorax.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesSteritalc
Novatech SA
Travel Grants
No travel grants are currently matched to Familial spontaneous pneumothorax.
Community
No community posts yet. Be the first to share your experience with Familial spontaneous pneumothorax.
Start the conversation →Latest news about Familial spontaneous pneumothorax
Disease timeline:
New recruiting trial: Clinical Characteristics and Outcome of Patients Xith Spontaneous Pneumothorax
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Optimal Postoperative Chest Tube and Pain Management in Patients Surgically Treated for Primary Spontaneous Pneumothorax (Pneumotrial)
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Outpatient Management of Primary Spontaneous Pneumothorax: Pigtail Catheter With Unidirectional Valve vs. Exsufflation, Randomized Prospective Study
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Study Compares Pneumothorax Recurrence: Absorbable Mesh vs. Pleurectomy in Primary Spontaneous Pneumothorax.
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Does Non-Steroidal Anti-inflammatory Drugs Decrease the Quality of Pleurodesis After Mechanical Pleural Abrasion/Pleurectomy for Treatment of Pneumothorax?
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
New recruiting trial: Prospective Study on Clinical Outcomes of Spontaneous Pneumothorax
A new clinical trial is recruiting patients for Familial spontaneous pneumothorax
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial spontaneous pneumothorax
What is Familial spontaneous pneumothorax?
Familial spontaneous pneumothorax (FSP) is a rare inherited condition characterized by the recurrent collapse of the lung (pneumothorax) without an obvious external cause, occurring in two or more members of the same family. A pneumothorax happens when air leaks into the space between the lung and the chest wall (pleural space), causing the lung to partially or fully collapse. Patients typically experience sudden onset of sharp chest pain, shortness of breath (dyspnea), and sometimes a dry cough. The condition predominantly affects the respiratory system and tends to occur in tall, thin indivi
Are there clinical trials for Familial spontaneous pneumothorax?
Yes — 1 recruiting clinical trial is currently listed for Familial spontaneous pneumothorax on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Familial spontaneous pneumothorax?
12 specialists and care centers treating Familial spontaneous pneumothorax are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Familial spontaneous pneumothorax?
1 patient support program are currently tracked on UniteRare for Familial spontaneous pneumothorax. See the treatments and support programs sections for copay assistance, eligibility, and contact details.